Resilient Revenue Base with Modest Organic Decline
Total revenue for 2025 was GBP 481.4m, down 2.7% organically versus prior year, with Europe growth largely offsetting EMS softness in North America and Asia.
Improved Adjusted Operating Profit and Margin Expansion
Adjusted operating profit increased 2.2% to GBP 37.2m and adjusted operating margin expanded by 30 basis points to 7.7%, driven by turnaround actions in North America, operational gearing in Europe and tighter cost control.
Strengthened Balance Sheet and Debt Reduction
Net debt reduced by almost GBP 30m to GBP 50.3m and leverage lowered to 1.1x from 1.8x year-on-year, supporting greater financial flexibility (revolving credit facility extended to June 2028 and reduced to GBP 105m).
Robust Cash Generation and Working Capital Improvements
Free cash flow rose to GBP 29.9m, up 7.9%; cash conversion improved to 150% from 117% last year; inventory reduction contributed GBP 14.8m in 2025 and GBP 27.6m over two years (2024–2025).
Regional Outperformance: Europe and Aerospace & Defense
Europe revenue grew 7.4% organically to GBP 144.4m with adjusted operating profit up 13.9% to GBP 22.1m and margin expanding 90 basis points to 15.3%. Aerospace & Defense end market grew 12% to GBP 152.8m, identified as a structural growth engine.
North America Turnaround
North America returned to profitability in H2: region revenue of GBP 173.1m (down 3.7% organically) but adjusted operating profit improved to GBP 1.2m vs a GBP 2.7m loss prior year; margins recovered to 0.7% (220 bps improvement); Cleveland site productivity, yield and on-time delivery materially improved.
Operational Stabilization and Site Actions
Plano production ceased as planned (site revenue GBP 13m in 2025); closure removes a structural drag going forward. Cleveland stabilization delivered sustained productivity above higher target levels and lowered rework/cost of poor quality.
Clear Value-Creation Priorities and Cost Program
Management announced a shift to 3 product-led divisions (Power, EMS, Components), a targeted cost-reset expected to deliver ~GBP 5m gross / ~GBP 3m net benefit in 2026 and ~double that annualized in future years, plus a sales transformation and portfolio optimization agenda.